Association between Serum Vitamin B12 Levels and the Degree of Steatosis in Patients with Nonalcoholic Fatty Liver Disease
Abstract
Purpose
A relationship between liver diseases and serum vitamin B12 levels was observed in previous reports. The purpose of this study was to determine if a similar relationship existed between vitamin B12 and nonalcoholic fatty liver disease (NAFLD), a common chronic liver disorder.
Materials and Methods
A total of 45 consecutive patients with NAFLD formed the NAFLD group, whereas 30 healthy controls (HC) formed the HC group. The subjects in all of the groups were of similar age and body mass index (BMI). A fatty liver is described in 3 ultrasonographic grades. Fasting blood samples were obtained, and serum vitamin B12 levels were measured. In addition, liver enzymes including aspartate aminotransferase, alanine aminotransferase (ALT), and alkaline phosphatase, and folic acid and other serum parameters were evaluated. The Mann-Whitney U test, χ2 test, and Spearman correlation analysis were used to compare the vitamin B12 levels and other serum parameters in both groups.
Results
The mean ± SD age and BMI of the NAFLD were 47.2 ± 11.2 and 28.8 ± 3.5. The mean ± SD age and BMI of the HC were 47.1 ± 8.8 and 27.7 ± 2.9, respectively. The serum aspartate aminotransferase and ALT levels of the patients with NAFLD were statistically higher compared with those of the controls (P = 0.001). The levels of vitamin B12 and folate were statistically lower in the NAFLD patients compared with those of the controls (P < 0.05). We found that there was a reduction of vitamin B12 levels, especially in grade 2 to grade 3 hepatosteatosis. In addition, in the Spearman correlation analysis between the vitamin B12 levels and ALT, the grade of fatty liver and the liver dimension were found to have an important negative correlation.
Conclusion
The serum vitamin B12 levels were significantly lower in the patients with NAFLD than in those of the control group; however, these still remain in the reference range. Consequently, low vitamin B12 levels may be associated with NAFLD especially in grade 2 to grade 3 hepatosteatosis.
Get full access to this article
View all access and purchase options for this article.
References
1. Saricam T, Kircali B, Koken T. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. Turk J Gastroenterol. 2005;16:65–70.
2. Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem. 2003;36:585–590.
3. Chen AR, Zhang HG, Wang ZP, et al. C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population. Clin Invest Med. 2010;33:290–297.
4. Jacobs M, van Greevenbroek MM, van der Kallen CJ, et al. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht study). Metabolism. 2010. >Epub ahead of print>.
5. Yajima Y, Ohta K, Narui T, et al. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med. 1983;139:43–50.
6. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708–2715.
7. Joseph AE, Saverymuttu SH, al-Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26–31.
8. Needleman L, Kurtz AB, Rifkin MD, et al. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol. 1986;146:1011–1015.
9. Acikel M, Sunay S, Koplay M, et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg. 2009;9:273–279.
10. Wang JT, Liu YL. Non -alcoholic fatty liver disease: the problems we are facing. Hepatobiliary Pancreat Dis Int. 2003;2:334–337.
11. Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845.
12. Schreuder TC, Verwer BJ, van Nieuwkerk CM, et al. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol. 2008;14:2474–2486.
13. Volkov I, Press Y, Rudoy I. Vitamin B12 could be a “master key” in the regulation of multiple pathological processes. J Nippon Med Sch. 2006;73:65–69.
14. Gulcan E, Toker S, Hatipoğlu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008;336:379–382.
15. Cylwik B, Czygier M, Daniluk M, et al. Vitamin B12 concentration in the blood of alcoholics. Pol Merkur Lekarski. 2010;28:122–125.
16. Fragasso A, Mannarella C, Ciancio A, et al. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anemic patients. Eur J Intern Med. 2010;21:97–100.
17. Holdsworth CD, Atkinson M, Dossett JA, et al. An assessment of the diagnostic and prognostic value of serum vitamin B12 levels in liver disease. Gut. 1964;5:601–606.
18. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888–1904.
19. Soda R, Tavassoli M, Jacobson DW. Receptor distribution and the endothelial uptake of transcobalamin II in liver cell suspensions. Blood. 1985;65:795–802.
20. Setola E, Monti LD, Galluccio E, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol. 2004;151:483–489.
21. Mehta SR, Thomas EL, Bell JD, et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476–3483.
22. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433–445.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: October 1, 2011
Issue published: October 2011
Keywords
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in Journal of Investigative Medicine.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 55
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 0
Crossref: 33
- Bi-directional causal effect between vitamin B12 and non-alcoholic fat...
- The Latest Evidence on the Association Between Vitamins and Non-alcoho...
- Busting the myth of methotrexate chronic hepatotoxicity
- Analysis of clinical findings and serum micronutrients in pediatric pa...
- The effects of vitamin B12 supplementation on metabolic profile of pat...
- Homocysteine, folate, and nonalcoholic fatty liver disease: a systemat...
- Correlation between long-term use of metformin and incidence of NAFLD ...
- Vitamin B12 and folate decrease inflammation and fibrosis in NASH by p...
- Central nervous system and systemic oxidative stress interplay with in...
- Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis an...
- On the prospects for the use of thiamine, pyridoxine, and cyanocobalam...
- VITAMIN B12 AND HOMOCYSTEINE LEVELS IN PATIENTS WITH NAFLD: A SYSTEMAT...
- COVID-19’s toll on the elderly and those with diabetes mellitus – Is v...
- NAFLD in the Elderly
- Role of micronutrients in staging of nonalcoholic fatty liver disease:...
- A Description of Risk Factors for Non-alcoholic Fatty Liver Disease in...
- Maternal vitamin B12 deficiency in rats alters DNA methylation in meta...
- Association between serum folate levels and fatty liver disease
- Obesity-Induced Non-alcoholic Fatty Liver Disease (NAFLD): Role of Hyp...
- Association Between Index of Nutritional Quality and Nonalcoholic Fatt...
- Non-alcoholic fatty liver disease and neurological defects
- Tissue-specific pathways and networks underlying sexual dimorphism in ...
- Non-alcoholic fatty liver disease and associated dietary and lifestyle...
- Folate and B12 Levels Correlate with Histological Severity in NASH Pat...
- Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
- Alkole bağlı olmayan karaciğer yağlanmasında transient elastografi (Fi...
- The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver ...
- Nutritional models of foetal programming and nutrigenomic and epigenom...
- Peculiarities of One-Carbon Metabolism in the Strict Carnivorous Cat a...
- Neurological complications post-liver transplantation: impact of nutri...
- Molecular and cellular effects of vitamin B12 in brain, myocardium and...
- Serum vitamin B12 and folate levels in patients with non-alcoholic fat...
- Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hy...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
AFMR members can access this journal content using society membership credentials.
AFMR members can access this journal content using society membership credentials.
Alternatively, view purchase options below:
Access journal content via a DeepDyve subscription or find out more about this option.
